Rickettsia rickettsii str. 'Sheila Smith'
Names | Rickettsia rickettsii str. 'Sheila Smith' |
---|---|
Accession numbers | NC_009882 |
Background | Rickettsia rickettsii is the causative agent of the Rocky Mountain spotted fever (RMSF) and is the prototype bacterium in the spotted fever group of rickettsiae. It is transmitted by hard ticks (Ixodidae). Rocky Mountain spotted fever is the most severe and most frequently reported rickettsial illness in the United States. It also occurs in Mexico and in Central and South America. The symptoms of the Rocky Mountain spotted fever may follow within one to fourteen days after the victim has been bitten. There is a high fever, with chills, muscle aches and a severe headache concentrated in the forehead area. Also, eyes may become red, muscles may feel weak and there may be body swelling. A rash also forms around the third to fifth day. RMSF affects about 800 people in the United States each year. Before anti-biotic treatment was available 20 to 30 percent of the cases were fatal. However, with the discovery of an antibiotic, the suffering and danger has decreased; it causes death in about 15 percent of its victims over age 70, and in only about two percent of infected victims under age 30. If an antibiotic is started rapidly, the mortality rate is ten percent.Rickettsia rickettsii (strain Iowa) is avirulent and defective in cell lysis. It does not induce fever in a guinea pig model of infection. A deletion truncates the rompA gene that codes for a major surface antigen. In addition R. rickettsii (strain Iowa) is defective in the processing of rOmpB, another major surface antigen. These factors most likely contribute to the avirulence of this strain. (HAMAP: RICRO) |
Taxonomy | |
Kingdom: | Bacteria |
Phylum: | Proteobacteria |
Class: | NA |
Order: | NA |
Family: | NA |
Genus: | NA |
Species: | NA |
Strain | 'Sheila Smith' |
Complete | Yes |
Sequencing centre | (03-OCT-2007) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA (27-SEP-2007) Neurogenomics Research Lab, University of Iowa, 200 B EMRB, Iowa City, IA 52242, USA |
Sequencing quality | Level 6: Finished |
Sequencing depth | NA |
Sequencing method | NA |
Isolation site | Patient with Rocky Mountain spotted fever |
Isolation country | NA |
Number of replicons | 1 |
Gram staining properties | Negative |
Shape | Bacilli |
Mobility | No |
Flagellar presence | No |
Number of membranes | 2 |
Oxygen requirements | Aerobic |
Optimal temperature | 37.0 |
Temperature range | Mesophilic |
Habitat | HostAssociated |
Biotic relationship | Symbiotic |
Host name | Homo sapiens |
Cell arrangement | NA |
Sporulation | Nonsporulating |
Metabolism | NA |
Energy source | NA |
Diseases | Rocky Mountain Spotted Fever |
Pathogenicity | No |
Citrate cycle (TCA cycle)
Pyrimidine metabolism
D-Alanine metabolism
Lipopolysaccharide biosynthesis
Peptidoglycan biosynthesis
One carbon pool by folate
Lipoic acid metabolism
Folate biosynthesis
Aminoacyl-tRNA biosynthesis
Pyrimidine metabolism
D-Alanine metabolism
Lipopolysaccharide biosynthesis
Peptidoglycan biosynthesis
One carbon pool by folate
Lipoic acid metabolism
Folate biosynthesis
Aminoacyl-tRNA biosynthesis